Company News
Zydus Lifesciences Completes Assertio Holdings Acquisition
Zydus Lifesciences completed cash tender offer for Assertio Holdings at $23.50 per share.
66.32% of Assertio shares were tendered, representing 4,286,488 shares accepted for payment.
Merger to make As
